These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24598393)
1. Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study. Thonnard M; Gosseries O; Demertzi A; Lugo Z; Vanhaudenhuyse A; Bruno MA; Chatelle C; Thibaut A; Charland-Verville V; Habbal D; Schnakers C; Laureys S Funct Neurol; 2013; 28(4):259-64. PubMed ID: 24598393 [TBL] [Abstract][Full Text] [Related]
2. Potential benefits of zolpidem in disorders of consciousness. Noormandi A; Shahrokhi M; Khalili H Expert Rev Clin Pharmacol; 2017 Sep; 10(9):983-992. PubMed ID: 28649875 [TBL] [Abstract][Full Text] [Related]
3. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Whyte J; Myers R Am J Phys Med Rehabil; 2009 May; 88(5):410-8. PubMed ID: 19620954 [TBL] [Abstract][Full Text] [Related]
4. The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness. Tucker C; Sandhu K Neurocrit Care; 2016 Jun; 24(3):488-93. PubMed ID: 26718349 [TBL] [Abstract][Full Text] [Related]
5. Zolpidem and restoration of consciousness. Whyte J; Rajan R; Rosenbaum A; Katz D; Kalmar K; Seel R; Greenwald B; Zafonte R; Demarest D; Brunner R; Kaelin D Am J Phys Med Rehabil; 2014 Feb; 93(2):101-13. PubMed ID: 24434886 [TBL] [Abstract][Full Text] [Related]
6. Speech recovery after single-dose zolpidem in two minimally conscious patients with severe traumatic brain injuries: a case report. Zhou Y; Altonji KA; Kakkanatt A; Greenwald BD Brain Inj; 2024 Apr; 38(5):337-340. PubMed ID: 38308526 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal Assessment of Clinical Signs of Recovery in Patients with Unresponsive Wakefulness Syndrome after Traumatic or Nontraumatic Brain Injury. Bagnato S; Boccagni C; Sant'Angelo A; Fingelkurts AA; Fingelkurts AA; Galardi G J Neurotrauma; 2017 Jan; 34(2):535-539. PubMed ID: 27149928 [TBL] [Abstract][Full Text] [Related]
8. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. Gosseries O; Charland-Verville V; Thonnard M; Bodart O; Laureys S; Demertzi A Curr Pharm Des; 2014; 20(26):4167-84. PubMed ID: 24025057 [TBL] [Abstract][Full Text] [Related]
9. Neuropsychological assessment through Coma Recovery Scale-Revised and Coma/Near Coma Scale in a sample of pediatric patients with disorder of consciousness. Frigerio S; Molteni E; Colombo K; Pastore V; Fedeli C; Galbiati S; Strazzer S J Neurol; 2023 Feb; 270(2):1019-1029. PubMed ID: 36335241 [TBL] [Abstract][Full Text] [Related]
10. The misdiagnosis of prolonged disorders of consciousness by a clinical consensus compared with repeated coma-recovery scale-revised assessment. Wang J; Hu X; Hu Z; Sun Z; Laureys S; Di H BMC Neurol; 2020 Sep; 20(1):343. PubMed ID: 32919461 [TBL] [Abstract][Full Text] [Related]
11. Intrinsic functional connectivity differentiates minimally conscious from unresponsive patients. Demertzi A; Antonopoulos G; Heine L; Voss HU; Crone JS; de Los Angeles C; Bahri MA; Di Perri C; Vanhaudenhuyse A; Charland-Verville V; Kronbichler M; Trinka E; Phillips C; Gomez F; Tshibanda L; Soddu A; Schiff ND; Whitfield-Gabrieli S; Laureys S Brain; 2015 Sep; 138(Pt 9):2619-31. PubMed ID: 26117367 [TBL] [Abstract][Full Text] [Related]
12. EEG dynamics induced by zolpidem forecast consciousness evolution in prolonged disorders of consciousness. Gao Q; Hao J; Kang X; Yuan F; Liu Y; Chen R; Liu X; Li R; Jiang W Clin Neurophysiol; 2023 Sep; 153():46-56. PubMed ID: 37454563 [TBL] [Abstract][Full Text] [Related]
13. Zolpidem for the Treatment of Neurologic Disorders: A Systematic Review. Bomalaski MN; Claflin ES; Townsend W; Peterson MD JAMA Neurol; 2017 Sep; 74(9):1130-1139. PubMed ID: 28655027 [TBL] [Abstract][Full Text] [Related]
15. Six-month outcomes in patients with hemorrhagic and non-hemorrhagic traumatic disorders of consciousness. Bagnato S; D'Ippolito ME; Boccagni C; De Tanti A; Lucca LF; Pingue V; Colombo V; Rubino F; Andriolo M Neurol Sci; 2022 Nov; 43(11):6511-6516. PubMed ID: 35978256 [TBL] [Abstract][Full Text] [Related]
16. Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem. Chatelle C; Thibaut A; Gosseries O; Bruno MA; Demertzi A; Bernard C; Hustinx R; Tshibanda L; Bahri MA; Laureys S Front Hum Neurosci; 2014; 8():917. PubMed ID: 25520636 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study. Stender J; Gosseries O; Bruno MA; Charland-Verville V; Vanhaudenhuyse A; Demertzi A; Chatelle C; Thonnard M; Thibaut A; Heine L; Soddu A; Boly M; Schnakers C; Gjedde A; Laureys S Lancet; 2014 Aug; 384(9942):514-22. PubMed ID: 24746174 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of the CRS-R index in patients with disorders of consciousness. Annen J; Filippini MM; Bonin E; Cassol H; Aubinet C; Carrière M; Gosseries O; Thibaut A; Barra A; Wolff A; Sanz LRD; Martial C; Laureys S; Chatelle C Brain Inj; 2019; 33(11):1409-1412. PubMed ID: 31319707 [No Abstract] [Full Text] [Related]
19. Outcome Prediction of Consciousness Disorders in the Acute Stage Based on a Complementary Motor Behavioural Tool. Pignat JM; Mauron E; Jöhr J; Gilart de Keranflec'h C; Van De Ville D; Preti MG; Meskaldji DE; Hömberg V; Laureys S; Draganski B; Frackowiak R; Diserens K PLoS One; 2016; 11(6):e0156882. PubMed ID: 27359335 [TBL] [Abstract][Full Text] [Related]
20. Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report. Appu M; Noetzel M Pediatr Neurol; 2014 Mar; 50(3):262-4. PubMed ID: 24417935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]